Cargando…
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
Bladder cancer is a common cancer; it is the tenth most common cancer in the world. Around one fourth of all diagnosed patients have muscle-invasive bladder cancer (MIBC), characterized by advanced tumors and which remains a lethal disease. The standard treatment for MIBC is the bladder removal by s...
Autores principales: | Silina, Linda, Dufour, Florent, Rapinat, Audrey, Reyes, Cécile, Gentien, David, Maksut, Fatlinda, Radvanyi, François, Verrelle, Pierre, Bernard-Pierrot, Isabelle, Mégnin-Chanet, Frédérique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368768/ https://www.ncbi.nlm.nih.gov/pubmed/35955805 http://dx.doi.org/10.3390/ijms23158671 |
Ejemplares similares
-
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives
por: Silina, Linda, et al.
Publicado: (2020) -
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019) -
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
por: Neyret-Kahn, Hélène, et al.
Publicado: (2023) -
The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2002) -
Targeting poly(ADP-ribose) polymerase activity for cancer therapy
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2010)